When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.

3. FDA approves new blood test to screen for colon cancer

   www.aol.com/news/fda-approves-blood-test-screen...

   Another colon cancer screening method includes fecal occult blood tests that detect blood in the stool, which can be a warning sign of colon polyps or cancer. The FIT-DNA tests, such as Cologuard ...

4. New blood test shows promising results for detecting colon cancer

   www.aol.com/blood-test-shows-promising-results...

   In a study of more than 7,800 colon cancer patients, the new test from Guardant Health was able to detect the cancer with 83% sensitivity. “The idea of a blood-based test is something they’re ...

5. M2-PK Test - Wikipedia

   en.wikipedia.org/wiki/M2-PK_Test

   The gold standard of early detection of colon polyp/cancer is the invasive colonoscopy, but with high expense about $557, while tumor marker M2-PK Test expense only about $15-$25. The invasive colonoscopy makes acceptance of it low among patients, so relatively cheap non-invasive M2-PK Test is a good choice for detection early polyp/cancer. [2]

6. Fecal immunochemical test - Wikipedia

   en.wikipedia.org/wiki/Fecal_immunochemical_test

   The fecal immunochemical test (FIT) is a diagnostic technique that examines stool samples for traces of non-visible blood, which could potentially indicate conditions including bowel cancer. [1] Symptoms which could be caused by bowel cancer and suggest a FIT include a change in bowel habit, anaemia, unexplained weight loss, and abdominal pain.

7. FDA approves new blood test for colorectal cancer screening

   www.aol.com/fda-approves-blood-test-colorectal...

   A new blood test to screen for colon cancer was approved Monday by the Food and Drug Administration (FDA), aimed at finding cancer when it’s still in the early stage and treatable. The blood ...